{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:05:02Z","timestamp":1778587502403,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.ejca.2017.03.029","type":"journal-article","created":{"date-parts":[[2017,6,7]],"date-time":"2017-06-07T08:00:40Z","timestamp":1496822440000},"page":"31-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Discrepancies in the use of chemotherapy and artificial nutrition near the end of life for hospitalised patients with metastatic gastric or oesophageal cancer. A countrywide, register-based study"],"prefix":"10.1016","volume":"79","author":[{"given":"Emmanuelle","family":"Kempf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Tournigand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Rochigneux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00e9gis","family":"Aubry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8486-8610","authenticated-orcid":false,"given":"Lucas","family":"Morin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejca.2017.03.029_bib1","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"issue":"16","key":"10.1016\/j.ejca.2017.03.029_bib2","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1200\/JCO.2014.60.1799","article-title":"Update on metastatic gastric and oesophageal cancers","volume":"33","author":"Shah","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2017.03.029_bib3","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/j.ejca.2015.07.026","article-title":"Survival for esophageal, stomach and small intestine cancers in Europe 1999\u20132007: results from EUROCARE-5","volume":"51","author":"Anderson","year":"2015","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1016\/j.ejca.2017.03.029_bib4","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMoa1000678","article-title":"Early palliative care for patients with metastatic non-small-cell lung cancer","volume":"363","author":"Temel","year":"2010","journal-title":"N Engl J Med"},{"issue":"9930","key":"10.1016\/j.ejca.2017.03.029_bib5","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0140-6736(13)62416-2","article-title":"Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial","volume":"383","author":"Zimmermann","year":"2014","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.ejca.2017.03.029_bib6","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1002\/cncr.29485","article-title":"Impact of aggressive management and palliative care on cancer costs in the final month of life","volume":"121","author":"Cheung","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2017.03.029_bib7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1472-684X-10-14","article-title":"The effect on survival of continuing chemotherapy to near death","volume":"10","author":"Saito","year":"2011","journal-title":"BMC Palliat Care"},{"key":"10.1016\/j.ejca.2017.03.029_bib8","doi-asserted-by":"crossref","first-page":"g1219","DOI":"10.1136\/bmj.g1219","article-title":"Associations between palliative chemotherapy and adult cancer patients' end of life care and place of death: prospective cohort study","volume":"348","author":"Wright","year":"2014","journal-title":"BMJ"},{"issue":"23","key":"10.1016\/j.ejca.2017.03.029_bib9","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1200\/JCO.2007.15.8253","article-title":"Aggressiveness of cancer care near the end of life: is it a quality-of-care issue?","volume":"26","author":"Earle","year":"2008","journal-title":"J Clin Oncol"},{"issue":"14","key":"10.1016\/j.ejca.2017.03.029_bib10","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1200\/JCO.2012.42.8375","article-title":"American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology","volume":"30","author":"Schnipper","year":"2012","journal-title":"J Clin Oncol"},{"issue":"22","key":"10.1016\/j.ejca.2017.03.029_bib11","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1001\/jama.299.22.2667","article-title":"The role of chemotherapy at the end of life: \u201cwhen is enough, enough?\u201d","volume":"299","author":"Harrington","year":"2008","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.ejca.2017.03.029_bib12","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1017\/S0007114511002509","article-title":"Importance of early nutritional screening in patients with gastric cancer","volume":"106","author":"Gavazzi","year":"2011","journal-title":"Br J Nutr"},{"issue":"6","key":"10.1016\/j.ejca.2017.03.029_bib13","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/sj.bjc.6605578","article-title":"Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres","volume":"102","author":"Pressoir","year":"2010","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.ejca.2017.03.029_bib14","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.clnu.2005.05.001","article-title":"An epidemiological evaluation of the prevalence of malnutrition in Spanish patients with locally advanced or metastatic cancer","volume":"24","author":"Segura","year":"2005","journal-title":"Clin Nutr"},{"key":"10.1016\/j.ejca.2017.03.029_bib15","first-page":"2111","article-title":"Parenteral nutrition support for patients with pancreatic cancer\u2013improvement of the nutritional status and the therapeutic outcome","volume":"32","author":"Richter","year":"2012","journal-title":"Anticancer Res"},{"issue":"Suppl. 2","key":"10.1016\/j.ejca.2017.03.029_bib16","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1007\/s00520-009-0664-9","article-title":"Nutritional support in patients with esophageal cancer","volume":"18","author":"Bozzetti","year":"2010","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2017.03.029_bib17","first-page":"30","article-title":"Enteral and parenteral nutrition in cancer patients: a systematic review and meta-analysis","volume":"5","author":"Chow","year":"2016","journal-title":"Ann Palliat Med"},{"issue":"4","key":"10.1016\/j.ejca.2017.03.029_bib18","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.nut.2014.12.004","article-title":"Nutritional support at the end of life","volume":"31","author":"Orrevall","year":"2015","journal-title":"Nutrition"},{"issue":"4","key":"10.1016\/j.ejca.2017.03.029_bib19","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.clnu.2009.04.011","article-title":"ESPEN guidelines on parenteral nutrition: non-surgical oncology","volume":"28","author":"Bozzetti","year":"2009","journal-title":"Clin Nutr"},{"issue":"2","key":"10.1016\/j.ejca.2017.03.029_bib20","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/jnci\/dji024","article-title":"The role of overdiagnosis and reclassification in the marked increase of oesophageal adenocarcinoma incidence","volume":"97","author":"Pohl","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.ejca.2017.03.029_bib21","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1001\/jama.2015.18603","article-title":"Comparison of site of death, health care utilization, and hospital expenditures for patients dying with cancer in 7 developed countries","volume":"315","author":"Bekelman","year":"2016","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ejca.2017.03.029_bib22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1200\/JCO.2004.08.136","article-title":"Trends in the aggressiveness of cancer care near the\u00a0end of life","volume":"22","author":"Earle","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2017.03.029_bib23","series-title":"Quality of end-of-life cancer care for medicare beneficiaries; regional and hospital-specific analyses. A report of the Dartmouth Atlas Project","author":"Goodman","year":"2010"},{"issue":"5","key":"10.1016\/j.ejca.2017.03.029_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpainsymman.2015.12.323","article-title":"Chemotherapy use in the months before death and estimated costs of care in the last week of life","volume":"51","author":"Garrido","year":"2016","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"10.1016\/j.ejca.2017.03.029_bib25","doi-asserted-by":"crossref","first-page":"e006724","DOI":"10.1136\/bmjopen-2014-006724","article-title":"A population-based observational study on the factors associated with the completion of palliative chemotherapy among patients with oesophagogastric cancer","volume":"5","author":"Groene","year":"2015","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.ejca.2017.03.029_bib26","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1001\/jamaoncol.2015.2378","article-title":"Chemotherapy use, performance status, and quality of life at the end of life","volume":"1","author":"Prigerson","year":"2015","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2017.03.029_bib27","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1377\/hlthaff.2011.0650","article-title":"End-of-life care for medicare beneficiaries with cancer is highly intensive overall and varies widely","volume":"31","author":"Morden","year":"2012","journal-title":"Health Aff"},{"issue":"5","key":"10.1016\/j.ejca.2017.03.029_bib28","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.ejca.2017.03.029_bib29","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1093\/annonc\/mdv365","article-title":"Development and validation of a nomogram to predict survival in incurable cachectic cancer patients on home parenteral nutrition","volume":"26","author":"Bozzetti","year":"2015","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2017.03.029_bib30","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ygyno.2006.02.013","article-title":"The effect of total parenteral nutrition on the survival of terminally ill ovarian cancer patients","volume":"103","author":"Brard","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.ejca.2017.03.029_bib31","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1093\/annonc\/mdq620","article-title":"Artificial nutrition and hydration in the last week of life in cancer patients. A systematic literature review of practices and effects","volume":"22","author":"Raijmakers","year":"2011","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2017.03.029_bib32","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrclinonc.2015.29","article-title":"Patient-reported outcomes as end points and outcome indicators in solid tumours","volume":"12","author":"Secord","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"issue":"7408","key":"10.1016\/j.ejca.2017.03.029_bib33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/bmj.327.7408.195","article-title":"A systematic review of physicians' survival predictions in terminally ill cancer patients","volume":"327","author":"Glare","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ejca.2017.03.029_bib34","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.clnu.2016.02.006","article-title":"ESPEN guideline on ethical aspects of artificial nutrition and hydration","volume":"35","author":"Druml","year":"2016","journal-title":"Clin Nutr"},{"issue":"17","key":"10.1016\/j.ejca.2017.03.029_bib35","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa1204410","article-title":"Patients' expectations about effects of chemotherapy for advanced cancer","volume":"367","author":"Weeks","year":"2012","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.ejca.2017.03.029_bib36","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1200\/JCO.2015.63.6696","article-title":"Discussions of life expectancy and changes in illness understanding in patients with advanced cancer","volume":"34","author":"Epstein","year":"2016","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1016\/j.ejca.2017.03.029_bib37","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1200\/JCO.2008.17.9515","article-title":"Patient involvement in decisions to limit treatment: the crucial role of agreement between physician and patient","volume":"27","author":"Winkler","year":"2009","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2017.03.029_bib38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nrclinonc.2015.201","article-title":"Integrating palliative care into the trajectory of cancer care","volume":"13","author":"Hui","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"issue":"12","key":"10.1016\/j.ejca.2017.03.029_bib39","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1007\/s00520-014-2337-6","article-title":"Decision making at the end of life\u2013cancer patients' and their caregivers' views on artificial nutrition and hydration","volume":"22","author":"B\u00fckki","year":"2014","journal-title":"Support Care Cancer"},{"issue":"22","key":"10.1016\/j.ejca.2017.03.029_bib40","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1001\/jama.292.22.2765","article-title":"Resurrecting treatment histories of dead patients: a study design that should be laid to rest","volume":"292","author":"Bach","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ejca.2017.03.029_bib41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1472-684X-11-25","article-title":"End-of-life medical decisions in France: a death certificate follow-up survey 5 years after the 2005 act of parliament on patients' rights and end of life","volume":"11","author":"Pennec","year":"2012","journal-title":"BMC Palliat Care"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804917308675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804917308675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T22:53:05Z","timestamp":1535755985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804917308675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":41,"alternative-id":["S0959804917308675"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2017.03.029","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discrepancies in the use of chemotherapy and artificial nutrition near the end of life for hospitalised patients with metastatic gastric or oesophageal cancer. A countrywide, register-based study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2017.03.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}